AI English summary of an SEC filing — figures as filed
Cencora CORThe company said its Board of Directors on August 13, 2024 appointed Frank Clyburn as a director, with the appointment effective October 1, 2024.
Key points
AI summaryThe company said its Board of Directors on August 13, 2024 appointed Frank Clyburn as a director, with the appointment effective October 1, 2024.
The company said the appointments of Frank Clyburn and of Robert P. Mauch, which was previously disclosed, both take effect on October 1, 2024, which will increase the Board from 11 to 13 members.
The company said Clyburn will receive the same benefits and compensation as the other non-employee directors under the non-employee director compensation policy, including the annual equity award, pro-rated for the period from the effective date to the date of the 2025 Annual Meeting of Stockholders.
The company said its press release described Clyburn as a new independent director, noting that he was formerly Chief Executive Officer of International Flavors and Fragrances Inc. and had served as Executive Vice President and President of Human Health at Merck.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Frank Clyburn Appointed Director, Effective October 1, 2024
The company said its Board of Directors on August 13, 2024 appointed Frank Clyburn as a director, with the appointment effective October 1, 2024.
Source · Based on the filing body and exhibits
Board Expands from 11 to 13 Members
The company said the appointments of Frank Clyburn and of Robert P. Mauch, which was previously disclosed, both take effect on October 1, 2024, which will increase the Board from 11 to 13 members.
Source · Based on the filing body and exhibits
Same Director Pay as Non-Employee Peers, Pro-Rated
The company said Clyburn will receive the same benefits and compensation as the other non-employee directors under the non-employee director compensation policy, including the annual equity award, pro-rated for the period from the effective date to the date of the 2025 Annual Meeting of Stockholders.
Source · Based on the filing body and exhibits
Independent Director Appointment and Clyburn's Background
The company said its press release described Clyburn as a new independent director, noting that he was formerly Chief Executive Officer of International Flavors and Fragrances Inc. and had served as Executive Vice President and President of Human Health at Merck.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…